Serum cystatin C as a new marker for determining the optimal dosage of renally excreted drugs
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-01-01
著者
-
TANIGAWARA Yusuke
Department of Pharmacy, School of Medicine, Keio University
-
Mihara Kiyoshi
Department of Biopharmaceutics, Meiji Pharmaceutical University
-
Mihara Kiyoshi
Department Of Pharmacy Keio University
-
MORITA Kunihiko
Department of Hospital Pharmacy, Keio University School of Medicine
-
Tanigawara Yusuke
Department Of Pharmacy Keio University
-
Tanigawara Yusuke
Department Of Clinical Pharmacokinetics And Pharmacodynamics School Of Medicine Keio University
-
Mihara Kiyoshi
Department Of Biopharmaceutics Meiji Pharmaceutical University
-
IKETANI Osamu
Department of Pharmacy, Keio University
-
Iketani Osamu
Department Of Pharmacy Keio University
-
Morita Kunihiko
Department Of Pharmacy Keio University
-
Morita Kunihiko
Department Of Clinical Laboratory Nisshin Orido Hospital
-
Iketani Osamu
Department of Hospital Pharmacy, Keio University Hospital
関連論文
- 高血圧症患者におけるオルメサルタン及びアゼルニジピンの比較薬力学 : 母集団薬物動態 / 薬力学解析
- Population Pharmacokinetics of R- and S-Carvedilol in Japanese Patients with Chronic Heart Failure
- S22-3 Pharmaco-proteomics and metabolomics for personalized medicine(FIP joint conference S22 International Conference Supported by FIP and JSPHCS Individualized Medicine: Bridging between Scientific and Clinical Studies)
- Phase I Study of Intravenous PSC-833 and Doxorubicin: Reversal of Multidrug Resistance
- Enantioselective and highly sensitive determination of carvedilol in human plasma and whole blood after administration of the racemate using normal-phase high-performance liquid chromatography
- MEAN RESIDENCE TIME IN ORGANS IN TOXICOKINETIC STUDIES
- 健康成人における塩酸ランジオロールの母集団薬物動態モデルの構築
- Reversal Effects of Ca2+ Antagonists on Multidrug Resistance via Down-regulation of MDR1 mRNA
- Single-institute phase 2 study of thalidomide treatment for refractory or relapsed multiple myeloma : Prognostic factors and unique toxicity profile
- MDR1-Mediated Interaction of Digoxin with Antiarrhythmic or Antianginal Drugs
- Factors Influencing the Prediction of Steady State Concentrations of Digoxin
- Interaction of Docetaxel ("Taxotere") with Human P-Glycoprotein
- Cellular Pharmacokinetic Aspects of Reversal Effect of Itraconazole on P-Glycoprotein-Mediated Resistance of Anticancer Drugs
- Inhibitory Effects of a Cyclosporin Derivative, SDZ PSC 833, on Transport of Doxorubicin and Vinblastine via Human P-Glycoprotein
- Thalidomide for the Treatment of Refractory Multiple Myeloma : Association of Plasma Concentrations of Thalidomide and Angiogenic Growth Factors with Clinical Outcome
- N-Acetyltransferase2 Genotype Correlated with Isoniazid Acetylation in Japanese Tuberculous Patients
- Effects of Secretable SOD Delivered by Genetically Modified Cells on Xanthine/Xanthine Oxidase and Paraquat-Induced Cytotoxicity in Vitro
- Effects of Cu, Zn-Superoxide Dismutase Delivered by Genetically Modified Skin Fibroblasts on Cold-Induced Skin Edema in Rats
- Protective Effect of Transfection with Secretable Superoxide Dismutase (SOD) (a Signal Sequence-SOD Fusion Protein Coding cDNA) Expression Vector on Superoxide Anion-Induced Cytotoxicity in Vitro)
- Effect of Transfection with a Superoxide Dismutase Expression Plasmid on Xanthine/Xanthine Oxidase-Induced Cytotoxicity in Cultured Rat Lung Cells
- Pharmaceutical Studies for Gene Therapy : Expression of Human Cu, Zn-Superoxide Dismutase Gene Transfected by Lipofection in Rat Skin Fibroblasts
- Effect of Transfection with Superoxide Dismutase Expression Plasmid on Superoxide Anion Induced Cytotoxicity in Cultured Rat Lung Cells
- Pharmacodynamic analysis of vancomycin effect alone and with serum proteins : using a novel in vitro model
- N-Acetyltransferase 2 Genotype-Related Sulfapyridine Acetylation and Its Adverse Events
- Sufficient effect of 1-week omeprazole and amoxicillin dual treatment for Helicobacter pylori eradication in cytochrome P450 2C19 poor metabolizers
- ミカファンギンの小児適応のためのポピュレーションPK解析
- Linear Pharmacokinetics of Micafungin and Its Active Metabolites in Japanese Pediatric Patients with Fungal Infections(Biopharmacy)
- A novel proteomic approach to determine possible biomarkers for acute rejection after small bowel transplantation
- Discovery of new biomarkers for acute rejection and therapeutic effect of immunosuppressive drugs in the rat liver transplantation : a comprehensive gene expression analysis
- Natural Killer Cell Activity in Mice after Intraperitoneal Administration of Beryllium Chloride
- Immune Response in Guinea Pigs Injected with Insoluble Beryllium Compounds
- The Influence of Beryllium on Cell Survival Rates in the In-vitro Culture System, on Intracellular DNA Synthesis and on SRBC-IgM Antibody Production Responses
- A study on the beryllium lymphocyte transformation test and the beryllium levels in working environment
- 感作性金属腹腔投与マウスにおけるリンパ球の動態について--感作性金属の細胞毒性に関する研究-3-
- A major influence of CYP2C19 genotype on the steady-state concentration of N-desmethylclobazam
- Influence of N-Terminal Peptide and Oligosaccharide on the Clearance of t-PA
- INHIBITION OF S-WARFARIN METABOLISM BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS IN HUMAN LIVER MICROSOMES IN VITRO
- The Novel Anticancer Drug KRN5500 Interacts with, but is Hardly Transported by, Human P-Glycoprotein
- Influence of Sugar Chain on Fibrin Affinity of Recombinat t-PA
- New biomarkers for acute rejection and therapeutic effect of immunosuppressive drugs in the rat cardiac transplantation by cDNA microarray analysis
- Relationship between Pharmacokinetic Parameters and Occurrence of Adverse Events in Clinical Trials Performed in Europe and United States for an Angiotensin II Receptor Antagonist, Telmisartan
- Pharmacokinetic Comparison of an Angiotensin II Receptor Antagonist, Telmisartan, in Japanese and Western Hypertensive Patients Using Population Pharmacokinetic Method
- Involvement of CYP2E in 8-Hydroxylation of Theophylline in Mouse Hepatic Microsomes-Difference from Its N-Demethylations
- Phorbol Myristate Acetate Stimulates Degradation of a Structural Analogue of Platelet-Activating Factor to a Neutral Lipid in Human Leukemic K562 Cells : Relevance to the Release of Lipids(Biochemistry/Molecular Biology)
- Prediction of the efficacy and safety of pioglitazone in patients with type 2 diabetes mellitus
- Serum cystatin C as a new marker for determining the optimal dosage of renally excreted drugs
- Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction
- Population Pharmacokinetics of an Angiotensin II Receptor Antagonist, Telmisartan, in Healthy Volunteers and Hypertensive Patients
- Population pharmacokinetics (PK) and pharmacodynamics (PD) of arbekacin in patients infected with methicillin-resistant Staphylococcus aureus (MRSA)
- Gefitinib / preliminary population pharmacokinetic analysis from a nested case-control study
- Optimal treatment schedule of meropenem for adult patients with febrile neutropenia based on pharmacokinetic-pharmacodynamic analysis
- A sharp fluctuation in peripheral blood cells shortly after dasatinib administration
- Drug-herbal interaction between tacrolimus and rooibos tea in a recipient of allogeneic hematopoietic stem cell transplantation
- Clinical dose findings of sitafloxacin treatment : pharmacokinetic-pharmacodynamic analysis of two clinical trial results for community-acquired respiratory tract infections
- Practice guidelines for therapeutic drug monitoring of voriconazole : a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring